The healthcare AI company focuses on early detection and management of chronic kidney disease through non-invasive digital biomarkers. They have developed an AI engine that uses proprietary renal hemodynamic modeling to detect and predict the progression of the disease. By leveraging computer vision and computational fluid dynamics, they are able to model the kidney microvascular and predict kidney flow, enabling doctors to detect CKD 10 years earlier than any existing system. Their solution provides early detection and personalized treatment options for better patient outcomes.